Histone deacetylase inhibitors in multiple myeloma

Novel drugs such as bortezomib and high dose chemotherapy combined with stem cell transplantation improved the outcome of multiple myeloma patients in the past decade. However, multiple myeloma often remains incurable due to the development of drug resistance governed by the bone marrow micro-enviro...

Full description

Bibliographic Details
Main Authors: Sarah Deleu, Eline Menu, Els Van Valckenborgh, Ben Van Camp, Joanna Fraczek, Isabelle Vande Broek, Vera Rogiers, Karin Vanderkerken
Format: Article
Language:English
Published: PAGEPress Publications 2009-06-01
Series:Hematology Reports
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/49

Similar Items